Mengxia Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mengxia Liu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Jianbin Li
Department of Rheumatism and Immunity, The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China
1 shared publication - Min Zhang
Department of Rheumatology and Immunology, The First Affiliated Hospital of Nanchang University, Nanchang, China
1 shared publication - Peng-Cheng Liu
Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
1 shared publication - Rui Wu
Department of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang City, China
1 shared publication - Yiping Huang
Department of Rheumatology and Immunology, The First Affiliated Hospital of Nanchang University, Nanchang, China
1 shared publication - Yueqin Zhang
Department of Rheumatology and Immunology, The First Affiliated Hospital of Nanchang University, Nanchang, China
1 shared publication
Latest Publications
- Open Access
- 3 November 2023
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 23 (6) , 922-935
S1P/S1PR signaling pathway advancements in autoimmune diseases
Sphingosine-1-phosphate (S1P) is a versatile sphingolipid that is generated through the phosphorylation of sphingosine by sphingosine kinase (SPHK). S1P exerts its functional effects by binding to the G protein-coupled S1P receptor (S1PR). This lipid mediator plays a pivotal role in various cellular activities. The S1P/S1PR signaling pathway is implicated in the pathogenesis of immune-mediated diseases, significantly contributing to the functioning of the immune system. It plays a crucial role in diverse physiological and pathophysiological processes, including cell survival, proliferation, migration, immune cell recruitment, synthesis of inflammatory mediators, and the formation of lymphatic and blood vessels. However, the full extent of the involvement of this signaling pathway in the development of autoimmune diseases remains to be fully elucidated. Therefore, this study aims to comprehensively review recent research on the S1P/S1PR axis in diseases related to autoimmunity.
- 3 November 2023
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 23 (6) , 922-935
Open AccessS1P/S1PR signaling pathway advancements in autoimmune diseases
Sphingosine-1-phosphate (S1P) is a versatile sphingolipid that is generated through the phosphorylation of sphingosine by sphingosine kinase (SPHK). S1P exerts its functional effects by binding to the G protein-coupled S1P receptor (S1PR). This lipid mediator plays a pivotal role in various cellular activities. The S1P/S1PR signaling pathway is implicated in the pathogenesis of immune-mediated diseases, significantly contributing to the functioning of the immune system. It plays a crucial role in diverse physiological and pathophysiological processes, including cell survival, proliferation, migration, immune cell recruitment, synthesis of inflammatory mediators, and the formation of lymphatic and blood vessels. However, the full extent of the involvement of this signaling pathway in the development of autoimmune diseases remains to be fully elucidated. Therefore, this study aims to comprehensively review recent research on the S1P/S1PR axis in diseases related to autoimmunity.